Cochlear Ltd. receives Investment Bank Analyst Rating Update
By Oliver Gray Investing.com - The S&P/ASX 200 fell 1.6% to 6700.2 on Wednesday as market participants braced for the U.S. Federal Reserve’s interest rate decision on Thursday...
EU attempting to revive Iran nuclear deal with market staying pessimistic Crude prices could rebound from oversold conditions but stay off 2022 highs Both Iran, US likely looking...
Cochlear Limited is an Australia-based company, which provides implantable hearing solutions and sound processor upgrades. The Company designs and offers products and accessories for adults or children. The Company operates through three segments: Cochlear implants, Services and Acoustics. Its Cochlear implants segment offers cochlear implant systems, including Cochlear, Nucleus, Profile Plus implant and Slim Modiolar Electrode (CI632). The Company’s Services segment offers sound processor upgrades, accessories and other, including Cochlear Nucleus 7 Sound Processor and Cochlear Nucleus Kanso 2 Sound Processor. Its Acoustics segment offers bone conduction systems and sound processor upgrades, including Cochlear Baha 6 Max Sound Processor and Cochlear Osia 2 System. The Company operates in America; Europe, the Middle East and Africa (EMEA), and Asia Pacific.
|Average||21,792.81 (+10,338.67% Upside)|
|No. of Analysts||16|